194 related articles for article (PubMed ID: 15454233)
21. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.
Béïque JC; Lavoie N; de Montigny C; Debonnel G
Eur J Pharmacol; 1998 May; 349(1):129-32. PubMed ID: 9669506
[TBL] [Abstract][Full Text] [Related]
22. 3 Beta-(4-ethyl-3-iodophenyl)nortropane-2 beta-carboxylic acid methyl ester as a high-affinity selective ligand for the serotonin transporter.
Blough BE; Abraham P; Mills AC; Lewin AH; Boja JW; Scheffel U; Kuhar MJ; Carroll FI
J Med Chem; 1997 Nov; 40(24):3861-4. PubMed ID: 9397165
[No Abstract] [Full Text] [Related]
23. Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.
Andrews M; Brown A; Chiva JY; Fradet D; Gordon D; Lansdell M; MacKenny M
Bioorg Med Chem Lett; 2009 Oct; 19(20):5893-7. PubMed ID: 19740658
[TBL] [Abstract][Full Text] [Related]
24. Further SAR studies of piperidine-based analogues of cocaine. 2. Potent dopamine and serotonin reuptake inhibitors.
Tamiz AP; Zhang J; Flippen-Anderson JL; Zhang M; Johnson KM; Deschaux O; Tella S; Kozikowski AP
J Med Chem; 2000 Mar; 43(6):1215-22. PubMed ID: 10737754
[TBL] [Abstract][Full Text] [Related]
25. Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.
Kim CY; Mahaney PE; McConnell O; Zhang Y; Manas E; Ho DM; Deecher DC; Trybulski EJ
Bioorg Med Chem Lett; 2009 Sep; 19(17):5029-32. PubMed ID: 19632110
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of 3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazoles, displaying combined 5-HT uptake inhibiting and alpha(2)-adrenoceptor antagonistic activities: a novel series of potential antidepressants.
Andrés JI; Alcázar J; Alonso JM; Alvarez RM; Cid JM; De Lucas AI; Fernández J; Martínez S; Nieto C; Pastor J; Bakker MH; Biesmans I; Heylen LI; Megens AA
Bioorg Med Chem Lett; 2003 Aug; 13(16):2719-25. PubMed ID: 12873501
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME
PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177
[TBL] [Abstract][Full Text] [Related]
28. Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats.
Davids E; Zhang K; Kula NS; Tarazi FI; Baldessarini RJ
J Pharmacol Exp Ther; 2002 Jun; 301(3):1097-102. PubMed ID: 12023542
[TBL] [Abstract][Full Text] [Related]
29. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
[TBL] [Abstract][Full Text] [Related]
30. 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.
Meltzer PC; Butler D; Deschamps JR; Madras BK
J Med Chem; 2006 Feb; 49(4):1420-32. PubMed ID: 16480278
[TBL] [Abstract][Full Text] [Related]
31. Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.
Tamiya J; Dyck B; Zhang M; Phan K; Fleck BA; Aparicio A; Jovic F; Tran JA; Vickers T; Grey J; Foster AC; Chen C
Bioorg Med Chem Lett; 2008 Jun; 18(11):3328-32. PubMed ID: 18445525
[TBL] [Abstract][Full Text] [Related]
32. Neurotransmission of cognition, part 3. Mechanism of action of selective NRIs: both dopamine and norepinephrine increase in prefrontal cortex.
Stahl SM
J Clin Psychiatry; 2003 Mar; 64(3):230-1. PubMed ID: 12716261
[TBL] [Abstract][Full Text] [Related]
33. 1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: further insights into a class of triple re-uptake inhibitors.
Micheli F; Cavanni P; Bettati M; Bonanomi G; Di Fabio R; Fazzolari E; Marchioro C; Roscic M; Tarsi L; Visentini F; Zonzini L; Worby A
Bioorg Med Chem; 2011 Jun; 19(11):3451-61. PubMed ID: 21550808
[TBL] [Abstract][Full Text] [Related]
34. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.
Bymaster FP; Dreshfield-Ahmad LJ; Threlkeld PG; Shaw JL; Thompson L; Nelson DL; Hemrick-Luecke SK; Wong DT
Neuropsychopharmacology; 2001 Dec; 25(6):871-80. PubMed ID: 11750180
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.
Hudson S; Kiankarimi M; Eccles W; Dwight W; Mostofi YS; Genicot MJ; Fleck BA; Gogas K; Aparicio A; Wang H; Wen J; Wade WS
Bioorg Med Chem Lett; 2008 Aug; 18(16):4491-4. PubMed ID: 18672364
[TBL] [Abstract][Full Text] [Related]
36. Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry.
Daws LC; Montañez S; Owens WA; Gould GG; Frazer A; Toney GM; Gerhardt GA
J Neurosci Methods; 2005 Apr; 143(1):49-62. PubMed ID: 15763136
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological activity of some known and putative duloxetine metabolites.
Kuo F; Gillespie TA; Kulanthaivel P; Lantz RJ; Ma TW; Nelson DL; Threlkeld PG; Wheeler WJ; Yi P; Zmijewski M
Bioorg Med Chem Lett; 2004 Jul; 14(13):3481-6. PubMed ID: 15177457
[TBL] [Abstract][Full Text] [Related]
38. [4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.
Fish PV; Ryckmans T; Stobie A; Wakenhut F
Bioorg Med Chem Lett; 2008 Mar; 18(6):1795-8. PubMed ID: 18313294
[TBL] [Abstract][Full Text] [Related]
39. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.
Owens MJ; Knight DL; Nemeroff CB
Biol Psychiatry; 2001 Sep; 50(5):345-50. PubMed ID: 11543737
[TBL] [Abstract][Full Text] [Related]
40. Studies towards the next generation of antidepressants. Part 1: Indolylcyclohexylamines as potent serotonin reuptake inhibitors.
Meagher KL; Mewshaw RE; Evrard DA; Zhou P; Smith DL; Scerni R; Spangler T; Abulhawa S; Shi X; Schechter LE; Andree TH
Bioorg Med Chem Lett; 2001 Jul; 11(14):1885-8. PubMed ID: 11459653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
